Education
About Us
Working with TipRanks
Follow Us
AEON Biopharma (AEON)
:AEON
Total Valuation
AEON Biopharma has a market cap or net worth of $4.32M. The enterprise value is $34.53M.
Market Cap$4.32M
Enterprise Value$34.53M
Share Statistics
AEON Biopharma has 10.53M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10.53M
Owned by Insiders1.91%
Owned by Instutions7.96%
Financial Efficiency
AEON Biopharma’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 7174.01%.
Return on Equity (ROE)18.28%
Return on Assets (ROA)-487.62%
Return on Invested Capital (ROIC)7174.01%
Return on Capital Employed (ROCE)67.45%
Revenue Per Employee$0
Profits Per Employee$7,984,600
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of AEON Biopharma is 0.00. AEON Biopharma’s PEG ratio is 0.00.
PE Ratio0.00
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.00
Income Statement
In the last 12 months, AEON Biopharma had revenue of $0.00 and earned $39.92M in profits. Earnings per share was $1.05.
Revenue$0.00
Gross Profit$0.00
Operating Income$75.31M
Pretax Income$39.92M
Net Income$39.92M
EBITDA-22.08M
Earnings Per Share (EPS)1.05
Cash Flow
In the last 12 months, operating cash flow was -$19.67M and capital expenditures $0.00, giving a free cash flow of -$19.67M billion.
Operating Cash Flow-$19.67M
Free Cash Flow-$19.67M
Free Cash Flow per Share-$1.87
Dividends & Yields
AEON Biopharma pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield0.00%
Earnings Yield―
Stock Price Statistics
Beta1.71
52-Week Price Change-99.92%
50-Day Moving Average2.98
200-Day Moving Average49.33
Relative Strength Index (RSI)23.69
Average Volume (3m)5.88M
Important Dates
AEON Biopharma upcoming earnings date is Mar 24, 2025, During Market Hours.
Last Earnings DateNov 13, 2024
Next Earnings DateMar 24, 2025
Ex-Dividend Date―
Financial Position
AEON Biopharma as a current ratio of 0.12, with Debt / Equity ratio of -0.46
Current Ratio0.12
Quick Ratio0.12
Debt to Market Cap0.00
Net Debt to EBITDA-2.52
Interest Coverage Ratio0.00
Taxes
In the past 12 months, AEON Biopharma has paid $107.59M in taxes.
Income Tax$107.59M
Effective Tax Rate0.31%
Enterprise Valuation
AEON Biopharma EV to EBITDA ratio is -2.52, with an EV/FCF ratio of -3.39.
EV to Sales0.00
EV to EBITDA-2.52
EV to Free Cash Flow-3.39
EV to Operating Cash Flow-3.42
Balance Sheet
AEON Biopharma has $537.00K in cash and marketable securities with $16.50M in debt, giving a net cash position of $15.96M billion.
Cash & Marketable Securities$537.00K
Total Debt$16.50M
Net Cash$15.96M
Net Cash Per Share$1.52
Tangible Book Value Per Share$0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for AEON Biopharma is , which is 11.43% higher than the current price. The consensus rating is
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast-261.69%